author-photo

Marina Cazzaniga

University of Milano-Bicocca

153

Papers

2263

Citations

Citation Trend

Filter By

Papers (153) Sort By

JournalConferenceOthers

203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (42)
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

2019 Journal of Cellular Physiology
Show All
- Source
- Cite
- Save
Citations (11)
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?

2019 OncoTargets and Therapy
Show All
- Source
- Cite
- Save
Citations (16)
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2– Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

2019 Breast Care
Show All
- Source
- Cite
- Save
Citations (0)
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH project.

2019 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (1)
Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly— Preliminary results of the GIM-13 AMBRA study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (1)
Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?

2018 Expert Review of Anticancer Therapy
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy of single administration of oral NEPA (netupitant plus palonosetron) and dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in breast cancer patients receiving adjuvant AC-based chemotherapy – Results from GIM15-NEPA Study

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号